Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.52 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.40 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL197984 | 1.00 | RNPEP (0.52) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL28090080 | 0.85 | RNPEP (0.50) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL28186076 | 0.83 | RNPEP (0.53) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL2872371 | 0.83 | RNPEP (0.52) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL2872370 | 0.83 | RNPEP (0.52) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL19545996 | 0.83 | RNPEP (0.42) | RNPEPFOLH1CHRNB2CHRNB4CHRNA3 | |
| SCHEMBL9781791 | 0.82 | RNPEP (0.52) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL9781788 | 0.82 | RNPEP (0.52) | RNPEPFOLH1FNTAFNTBLMNA | |
| Hydrochloric Acid SCHEMBL5680481 | 0.82 | RNPEP (0.52) | RNPEPFOLH1FNTAFNTBLMNA | |
| SCHEMBL22384085 | 0.82 | RNPEP (0.47) | RNPEPFOLH1FNTAFNTBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160244484-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2016-08-25 | — | — | US | claimed |
| EP-3049428-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | Dr. August Wolff GmbH & Co. KG Arzneimittel (DE) | 2016-08-03 | — | — | EP | claimed |
| CN-105102475-A | Sodium channel sensitive conopeptides and analogs, including compositions and methods thereof | UNIV UTAH RES FOUND | 2015-11-25 | — | — | CN | claimed |
| WO-2015040235-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2015-03-26 | — | — | WO | claimed |
| US-20210087593-A1 | N-ALKYLATION OF ALKALOID COMPOUNDS | WILLOW BIOSCIENCES INC (CA) | 2021-03-25 | — | — | US | disclosed |
| US-10954269-B2 | Anti-inflammatory tripeptides | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2021-03-23 | — | — | US | disclosed |
| US-10676767-B2 | Methods and compositions for making ephedrine and related alkaloid compounds | Willow Biosciences Inc. (CA) | 2020-06-09 | — | — | US | disclosed |
| US-20190153029-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2019-05-23 | — | — | US | disclosed |
| US-10227379-B2 | Anti-inflammatory tripeptides | DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) | 2019-03-12 | — | — | US | disclosed |
| US-20180179561-A1 | Methods and Compositions For Making Ephedrine and Related Alkaloid Compounds | Willow Biosciences Inc. (CA) | 2018-06-28 | — | — | US | disclosed |
| EP-3314001-A1 | METHODS AND COMPOSITIONS FOR MAKING EPHEDRINE AND RELATED ALKALOID COMPOUNDS | Serturner Corp. (CA) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016205939-A1 | METHODS AND COMPOSITIONS FOR MAKING EPHEDRINE AND RELATED ALKALOID COMPOUNDS | SERTURNER CORP. (CA) | 2016-12-29 | — | — | WO | disclosed |
| CN-101365716-B | Mu-conotoxin peptides and their use as local anesthetics | ATHERIS LAB | 2014-07-16 | — | — | CN | disclosed |
| US-8158330-B2 | Resist protective coating composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-04-17 | — | — | US | disclosed |
| US-8088537-B2 | Resist top coat composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2012-01-03 | — | — | US | disclosed |
| US-20090286182-A1 | RESIST PROTECTIVE COATING COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-11-19 | — | — | US | disclosed |
| US-20090197200-A1 | Resist top coat composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-08-06 | — | — | US | disclosed |
| CN-101365716-A | Mu-conotoxin peptides and their use as local anesthetics | ATHERIS LAB (CH) | 2009-02-11 | — | — | CN | disclosed |
| US-5744678-A | NICKEL COMPOUND, ORGANOPHOSPHORUS COMPOUND, ORGANOALUMINUM COMPOUND, CARBON-HALOGEN COMPOUNDS; CATALYST SELECTIVITY | NIPPON OIL CO., LTD. (JP) | 1998-04-28 | — | — | US | disclosed |
| EP-0758563-A1 | OLEFIN OLIGOMERIZATION CATALYST AND PROCESS FOR THE PREPARATION OF OLEFIN OLIGOMER USING IT | NIPPON OIL COMPANY, LTD. (JP) | 1997-02-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160244484-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | VIP, TNF, ENPEP | RNPEP 85/4885FOLH1 173/4885FNTA 1133/4885 |
| US-20190153029-A1 | ANTI-INFLAMMATORY TRIPEPTIDES | VIP, TNF, ENPEP | RNPEP 85/4885FOLH1 173/4885FNTA 1133/4885 |
| US-10954269-B2 | Anti-inflammatory tripeptides | VIP, TNF, ENPEP | RNPEP 85/4885FOLH1 173/4885FNTA 1133/4885 |
| US-10676767-B2 | Methods and compositions for making ephedrine and related alkaloid compounds | PNMT, GNMT, BHMT | RNPEP 502/4885FOLH1 871/4885FNTA 470/4885 |
| US-10227379-B2 | Anti-inflammatory tripeptides | VIP, TNF, ENPEP | RNPEP 85/4885FOLH1 173/4885FNTA 1133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.